Fig. 4From: Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug developmentPotential therapies for CIPN caused by oxaliplatin. Repurposed drugs and preclinically tested lead compounds for OIPNBack to article page